Catalyst Wire Dossier Catalyst Wire Dossier

RV6153

· Respivert Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RV6153, covering 2016-03-04 to 2016-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153 [Phase 1]

See pricing